---
figid: PMC7226025__biomolecules-10-00496-g003
figlink: pmc/articles/PMC7226025/figure/biomolecules-10-00496-f003/
number: F3
caption: Potential consequences of fructose metabolism in hepatocellular carcinoma
  (HCC). A traditional HCC cancer cell may exhibit the Warburg effect where glycolysis
  is favored to produce ATP and glycolytic products for nucleotide synthesis. If this
  cancer cell is exposed to fructose as the only source of fuel, the toxic effects
  of fructose may be deleterious to the cell by depleting energy and increasing ROS,
  leading to cell death. However, in cancer cells exposed to high concentrations of
  fructose, the cancer cell may metabolically adapt to sustain growth through activation
  of the MCT and gluconeogenic enzymes. In this case the cell switches to the ‘reverse
  Warburg effect’ to utilize fructose by-products to fuel nucleotide synthesis and
  to uptake catabolites from neighbouring cells for production of energy and antioxidants.
  ATP, adenosine triphosphate; AMP, adenosine monophosphate; DHAP, dihydroxyacetone
  phosphate; F1P. P, fructose-1-phosphate; G6P, glucose-6-phosphate; Glut1, glucose
  transporter 1; Glut2, glucose transporter 2; Glut5, glucose transporter 5; KHK-A,
  ketohexokinase-A; KHK-C, ketohexokinase-C; MCT, monocarboxylate transporters; PPP,
  pentose phosphate pathway; ROS, reactive oxygen species; SGS, serine to glycine
  synthesis pathway; TCA, tricarboxylic acid cycle (citric acid cycle).
pmcid: PMC7226025
papertitle: A Sweet Connection? Fructose’s Role in Hepatocellular Carcinoma.
reftext: Brittany Dewdney, et al. Biomolecules. 2020 Apr;10(4):496.
pmc_ranked_result_index: '9094'
pathway_score: 0.9457471
filename: biomolecules-10-00496-g003.jpg
figtitle: Consequences of fructose metabolism in hepatocellular carcinoma (HCC)
year: '2020'
organisms:
- Mus musculus
- Rattus norvegicus
- Hepatitis B virus
- Limosilactobacillus reuteri
- Lacticaseibacillus casei str. Zhang
- Lacticaseibacillus rhamnosus GG
- gut metagenome
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7226025__biomolecules-10-00496-g003.html
  '@type': Dataset
  description: Potential consequences of fructose metabolism in hepatocellular carcinoma
    (HCC). A traditional HCC cancer cell may exhibit the Warburg effect where glycolysis
    is favored to produce ATP and glycolytic products for nucleotide synthesis. If
    this cancer cell is exposed to fructose as the only source of fuel, the toxic
    effects of fructose may be deleterious to the cell by depleting energy and increasing
    ROS, leading to cell death. However, in cancer cells exposed to high concentrations
    of fructose, the cancer cell may metabolically adapt to sustain growth through
    activation of the MCT and gluconeogenic enzymes. In this case the cell switches
    to the ‘reverse Warburg effect’ to utilize fructose by-products to fuel nucleotide
    synthesis and to uptake catabolites from neighbouring cells for production of
    energy and antioxidants. ATP, adenosine triphosphate; AMP, adenosine monophosphate;
    DHAP, dihydroxyacetone phosphate; F1P. P, fructose-1-phosphate; G6P, glucose-6-phosphate;
    Glut1, glucose transporter 1; Glut2, glucose transporter 2; Glut5, glucose transporter
    5; KHK-A, ketohexokinase-A; KHK-C, ketohexokinase-C; MCT, monocarboxylate transporters;
    PPP, pentose phosphate pathway; ROS, reactive oxygen species; SGS, serine to glycine
    synthesis pathway; TCA, tricarboxylic acid cycle (citric acid cycle).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SLC2A2
  - FAM126A
  - MFAP1
  - FBN1
  - USF2
  - Fructose
  - Glucose
  - AMP
  - AMP AMP
  - Fatty acids
  - Uric acid
  - Citrate
  - NADPH
  - 3-P-Glycerate
  - ATP
  - Pyruvate Lactate
  - TCA
  - DHAP
  - Glyceraldehyde
  - Lactate
  - Ketones
  - Glutathione
  - Glutamate
  - Glutamine
  - Fructose toxicity
genes:
- word: Glut2
  symbol: GLUT2
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A2
  entrez: '6514'
- word: HCC
  symbol: HCC
  source: hgnc_alias_symbol
  hgnc_symbol: FAM126A
  entrez: '84668'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: SGS
  symbol: SGS
  source: hgnc_alias_symbol
  hgnc_symbol: FBN1
  entrez: '2200'
- word: →SGS
  symbol: SGS
  source: hgnc_alias_symbol
  hgnc_symbol: FBN1
  entrez: '2200'
- word: FIP
  symbol: FIP
  source: hgnc_alias_symbol
  hgnc_symbol: USF2
  entrez: '7392'
chemicals:
- word: Fructose
  source: MESH
  identifier: D005632
- word: Glucose
  source: MESH
  identifier: D005947
- word: AMP
  source: MESH
  identifier: D000249
- word: AMP AMP
  source: MESH
  identifier: D000249
- word: Fatty acids
  source: MESH
  identifier: D005227
- word: Uric acid
  source: MESH
  identifier: D014527
- word: Citrate
  source: MESH
  identifier: C102006
- word: NADPH
  source: MESH
  identifier: D009249
- word: 3-P-Glycerate
  source: MESH
  identifier: C005156
- word: ATP
  source: MESH
  identifier: D000255
- word: Pyruvate Lactate
  source: MESH
  identifier: D019344
- word: TCA
  source: MESH
  identifier: C000589078
- word: DHAP
  source: MESH
  identifier: C017202
- word: Glyceraldehyde
  source: MESH
  identifier: D005985
- word: Lactate
  source: MESH
  identifier: D019344
- word: Ketones
  source: MESH
  identifier: D007659
- word: Glutathione
  source: MESH
  identifier: D005978
- word: Glutamate
  source: ''
  identifier: ''
- word: Glutamine
  source: MESH
  identifier: C578860
diseases:
- word: Fructose toxicity
  source: MESH
  identifier: D005633
figid_alias: PMC7226025__F3
redirect_from: /figures/PMC7226025__F3
figtype: Figure
---
